Evolutionary Genomics, Inc. (FNAM)
Evolutionary Genomics, Inc., engages in the research and identification of positively selected genes in humans, animals, and commercial crops.
$0.00+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+0.0%
The outlook
Evolutionary Genomics, Inc. currently reads as neutral based on above its 50- & 200-day averages, 0% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$1,331
52-wk high
$0.45
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—